Agneta Heierson
Corporate Officer/Principal at INFANT BACTERIAL THERAPEUTICS AB
Profile
Agneta Heierson is currently the Vice President-Clinical Development at Infant Bacterial Therapeutics AB.
She previously worked as the Global VP-Research & Development Supply Chain at AstraZeneca AB.
Agneta Heierson active positions
Companies | Position | Start |
---|---|---|
INFANT BACTERIAL THERAPEUTICS AB | Corporate Officer/Principal | - |
Former positions of Agneta Heierson
Companies | Position | End |
---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
Private companies | 1 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Agneta Heierson